Medicare is preparing to make medical supply companies compete against each other on prices. But as host Bob Moon learns from New York Times business columnist David Leonhardt, there may be a fight ahead.
Lipitor is the world's best-selling drug, but Pfizer, the maker of the cholesterol medication, has a strong patent protecting it against generics. A new agreement will change that in a few years. Janet Babin reports.
A new drug called bapineuzumab has potential to be a strong weapon against Alzheimer's disease. While risks are still being assessed, drug sales could hit $3 billion if the final trial goes well. Janet Babin reports.
The American Medical Association is concerned over the trend of people traveling abroad for better health care. So members are voting on a set of key principles that would act as a guideline for the move. Ashley Milne-Tyte has more.
Want to help fight a deadly disease but don't have any money to contribute to research? The Seattle Biomedical Research Institute can enlist you to contract the disease -- and even get paid for it. Ethan Lindsey has more.
The FDA says tomatoes harvested after May 1 in California and Florida are safe to eat. But that doesn't mean you're going to see them stockpiled at your local grocer just yet. Ashley Milne-Tyte reports.